AGF Logo
  • Home
  • Industry and Expert Views
  • Investing and Market Views
  • Capitol Insights
  • Français
  • AGF.com
Skip to content
AGF logo
Insights and Market Perspectives
  • Industry and Expert Views
  • Investing and Market Views
  • Capitol Insights
  • Contributors
  • Français
  • Search
Search
Close
Time to bet on genomics?

  • Investing and Market Views

For Print Only Logo
Insights and Market Perspectives

Time to bet on genomics?

Author: Carmen Tang

November 12, 2018

Advancements in biotechnology, genome sequencing and gene editing have given rise to whole new areas in health care—and created new opportunities for investors. Carmen Tang explains.

Can’t view the video?  Click here to view in your browser.

About AGF Management Limited

Founded in 1957, AGF Management Limited (AGF) is an independent and globally diverse asset management firm. AGF brings a disciplined approach to delivering excellence in investment management through its fundamental, quantitative, alternative and high-net-worth businesses focused on providing an exceptional client experience. AGF’s suite of investment solutions extends globally to a wide range of clients, from financial advisors and individual investors to institutional investors including pension plans, corporate plans, sovereign wealth funds and endowments and foundations.

For further information, please visit AGF.com.

© 2023 AGF Management Limited. All rights reserved.

Written by

Carmen Tang

Carmen Tang, MSc., MBA, CFA®

Equity Analyst

AGF Investments Inc.

More from Carmen Tang

  • Investing and Market Views

A Check Up on Healthcare Stocks: Recent Outperformance and the Impact of the U.S. Inflation Reduction Act

November 15, 2022

  • Investing and Market Views

An Investor’s Cheat Sheet on the Vaccine

December 14, 2020

  • Investing and Market Views

The Distance Between Us and a Vaccine

March 24, 2020

  • Investing and Market Views

Biotech and the Race for a Vaccine

March 13, 2020

Get perspectives straight to your inbox.

Subscribe now

More articles like this

Downshifting Equities to Neutral

  • Investing and Market Views

Downshifting Equities to Neutral

Kevin McCreadie | January 17, 2023

Kevin McCreadie, AGF’s CEO and Chief Investment Officer, discusses the AGF Asset Allocation Committee’s latest quarterly update and the “return to normal.”

Read More
An Alternative(s) Take on the New Year

  • Investing and Market Views

An Alternative(s) Take on the New Year

Ash Lawrence | January 13, 2023

The important role alternative investments can play in support of a 60/40 portfolio.

Read More
Yes, Markets Are Oversold. But Investors Still Need to Be Cautious

  • Investing and Market Views

Yes, Markets Are Oversold. But Investors Still Need to Be Cautious

Abhishek Ashok | November 24, 2022

Every month (or so), AGFiQ highlights the quantitative investment factors that are helping shape equity markets. Today’s focus is oversold conditions and the risk of weakening economic and earnings data.

Read More
AGF Logo
  • Industry and Expert Views
  • Investing and Market Views
  • Capitol Insights
Follow AGF

AGF Web Site Pages © 2023 AGF Management Limited. All rights reserved.

  • Terms & Conditions
  • Privacy
  • AGF.com